SINGAPORE (Apr 16): RHB is maintaining its “buy” on Manulife US REIT but raising its target to US$1 from 98 US cents to factor in 1-2% higher FY18-20 DPU forecasts on contributions from its latest acquisitions.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply